
Mandible Pharmaceuticals Private Limited
About Mandible Pharmaceuticals Private Limited
Data last updated:
Mandible Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 15 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2021PTC383718.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Rajesh Ranjan Rashmirathy and Amit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Arti Kumari Room No. 119 Plot No 19 Kadambari Apartment Rohini, Delhi, India – 110085.
Company details
Contact details
Mandible Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC/O Arti Kumari Room No. 119 Plot No 19 Kadambari Apartment Rohini, Delhi, India – 110085
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mandible Pharmaceuticals Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Mandible Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mandible Pharmaceuticals Private Limited
Mandible Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Ranjan Rashmirathy | Director | 15 Jul 2021 | 5 Years 4 Months | Current |
| Amit Kumar | Director | 15 Jul 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Mandible Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mandible Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mandible Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mandible Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Sapna Kumari ceased to be Director on 08 Mar 2024.
Frequently asked questions
Mandible Pharmaceuticals is an active private limited company based in Delhi, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 15 July 2021 (5+ years old) and is registered under CIN U24110DL2021PTC383718.
Mandible Pharmaceuticals has 2 current directors:
- Rajesh Ranjan Rashmirathy - Director
- Amit Kumar - Director
The latest financial statements of Mandible Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Mandible Pharmaceuticals is U24110DL2021PTC383718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mandible Pharmaceuticals was incorporated on 15 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Sapna Kumari ceased to be Director on 08 Mar 2024. Amit Kumar was appointed as Director on 15 Jul 2021. Rajesh Ranjan Rashmirathy was appointed as Director on 15 Jul 2021.
The registered office of Mandible Pharmaceuticals is at CO Arti Kumari Room No. 119 Plot No 19 Kadambari Apartment Rohini, Delhi, India – 110085.
Mandible Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
Mandible Pharmaceuticals can be reached at its registered office: CO Arti Kumari Room No. 119 Plot No 19 Kadambari Apartment Rohini, Delhi, India – 110085.
Mandible Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

